Amarin reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
AstraZeneca AZN:LN USD 29.3B 229M
Biocryst Pharmaceuticals BCRX:US USD 713.65M 91.47M
Esperion Therapeutics ESPR:US USD 259.49M 407K
GlaxoSmithKline GSK:LN GBP 22.12B 4M
Halozyme Therapeutics HALO:US USD 1.5B 258.29M
Heron Therapeutics HRTX:US USD 149.23M 52K
Intercept Pharmaceuticals ICPT:US USD 332.31M 381.55M
IONIS PHARMACEUT IONS:US USD 1.25B 1.34M
JAZZ PHA JAZZ:US USD 5.73B 294.18M
Neurocrine Biosciences NBIX:US USD 169.2M 200K
Novartis NOVN:VX USD 28.44B 2.59B
Teva Pharmaceutical Industries TEVA:US USD 21.27B 816M